Health Canada drug identification number

DIN 00115630 — LIBRAX 2.5 MG; 5 MG

LIBRAX is a capsule of Clidinium / Chlordiazepoxide marketed by BAUSCH HEALTH, CANADA INC.. The full Clidinium / Chlordiazepoxide monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
00115630
Brand name
LIBRAX
Strength
2.5 MG; 5 MG
Dosage form
CAPSULE
Route
ORAL
Manufacturer
BAUSCH HEALTH, CANADA INC.
Health Canada status
MARKETED
Drug class
Anticholinergic / benzodiazepine combination (anxiolytic-antispasmodic)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Clidinium / Chlordiazepoxide products

DINBrandStrengthFormManufacturerStatus
00618454 CHLORAX 2.5 MG; 5 MG CAPSULE AA PHARMA INC DORMANT

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.